In previous studies, circulating cardiac biomarkers, including troponin T (TnT) and N-terminal probrain natriuretic peptide (NTproBNP), were considered predictors of cardiovascular adverse events in the general population and patients with diabetes [116]. The gene discussed is NPPB; the disease is diabetes mellitus.